Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery.
Mark R EdwardsGordon ForbesNeil MacDonaldVladislav BerdunovBorislava MihaylovaPriyanthi DiasAnn ThomsonMichael Pw GrocottMonty G MythenMike A GilliesMichael SanderTuong D PhanLisbeth EveredDuminda Nalaka WijeysunderaStuart A McCluskeyCesar AldecoaJavier Ripollés-MelchorChristoph K HoferHussein AbukhudairWojciech SzczeklikIoana GrigorasLudhmila A HajjarBrennan C KahanRupert M Pearsenull nullPublished in: BMJ open (2019)
ISRCTN39653756.
Keyphrases
- patients undergoing
- low dose
- study protocol
- clinical trial
- phase iii
- phase ii
- minimally invasive
- healthcare
- randomized controlled trial
- palliative care
- high dose
- coronary artery bypass
- left ventricular
- quality improvement
- open label
- double blind
- cardiac surgery
- stem cells
- heart failure
- coronary artery disease
- bone marrow
- chronic pain
- percutaneous coronary intervention
- mesenchymal stem cells